WO1982000363A1 - Immunosubstrate and immunoadsorptive surface coating for solid-phase immunosubstrate - Google Patents
Immunosubstrate and immunoadsorptive surface coating for solid-phase immunosubstrate Download PDFInfo
- Publication number
- WO1982000363A1 WO1982000363A1 PCT/US1981/000973 US8100973W WO8200363A1 WO 1982000363 A1 WO1982000363 A1 WO 1982000363A1 US 8100973 W US8100973 W US 8100973W WO 8200363 A1 WO8200363 A1 WO 8200363A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating
- immunosubstrate
- polymer beads
- water
- recited
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 148
- 239000011248 coating agent Substances 0.000 title claims abstract description 147
- 239000007790 solid phase Substances 0.000 title claims abstract description 54
- 239000011324 bead Substances 0.000 claims abstract description 75
- 229920000642 polymer Polymers 0.000 claims abstract description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 238000000149 argon plasma sintering Methods 0.000 claims abstract description 41
- 239000004816 latex Substances 0.000 claims abstract description 36
- 229920000126 latex Polymers 0.000 claims abstract description 36
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 22
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 15
- 239000006174 pH buffer Substances 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 239000000417 fungicide Substances 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 11
- 229920001577 copolymer Polymers 0.000 claims description 10
- 239000004408 titanium dioxide Substances 0.000 claims description 10
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000004927 clay Substances 0.000 claims description 8
- 239000011118 polyvinyl acetate Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 4
- 230000036046 immunoreaction Effects 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 235000010215 titanium dioxide Nutrition 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims 7
- 229920000058 polyacrylate Polymers 0.000 claims 5
- 238000010324 immunological assay Methods 0.000 claims 4
- 239000000463 material Substances 0.000 abstract description 13
- 238000005406 washing Methods 0.000 abstract description 6
- 238000003018 immunoassay Methods 0.000 abstract description 5
- 238000001179 sorption measurement Methods 0.000 abstract description 5
- 230000000274 adsorptive effect Effects 0.000 abstract description 4
- 238000003556 assay Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 description 20
- 102000036639 antigens Human genes 0.000 description 20
- 108091007433 antigens Proteins 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 9
- 230000027455 binding Effects 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003460 anti-nuclear Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000000984 immunochemical effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 102000019040 Nuclear Antigens Human genes 0.000 description 1
- 108010051791 Nuclear Antigens Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
- Y10T428/252—Glass or ceramic [i.e., fired or glazed clay, cement, etc.] [porcelain, quartz, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
- Y10T428/253—Cellulosic [e.g., wood, paper, cork, rayon, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
- Y10T428/254—Polymeric or resinous material
Definitions
- the present invention relates generally to solid-phase iiranuno substrates, for use in immunological assaying and more particularly to a surface coating or film for application to a solid-phase surface and to the immunosubstrate formed by the utilization of the surface coating.
- the solid-phase may be a metallic surface, such as is employed in polarization change studies, or a glass or smooth plastic surface in which the protein is fixed onto the surface by air drying, heat denaturation or the use of organic fixing agents such as acetone, ethanol, methanol or formaldehyde.
- organic fixing agents such as acetone, ethanol, methanol or formaldehyde.
- Cellulose and cellulose derivatives such as mixtures of cellulose acetates and cellulose nitrates, have also been utilized as adsorptive surfaces for protein binding.
- the surface coating or film of the present invention is applied to solid-phase surfaces to increase adsorption and retention of immunoreagents.
- Its main constituent is a water based emulsion of microdiameter size polymer beads to which may be added a material which imparts light scattering centers into the coating.
- No prior art is known to the inventors that utilizes such polymer beads within a surface coating for solid-phase surfaces, nor that combines them with a material providing optical properties that improves the fluorescent testing capability of the immunosubstrate formed through the use of the surface coating.
- the immunoadsorptive surface coating of the present invention includes a water based emulsion of dispersed polymer beads of microdiameter size. Where the coating is to be used in an optical testing situation, such as fluorescence testing, additional materials may be added to the coating to provide light scattering centers within the coating.
- the polymer may be an acrylic, polyvinyl acetate or butadiene-styrene copolymer or a combination thereof, and a source of light scattering centers may be starch, titanium dioxide, silicon dioxide or finely powdered clay or a combination thereof .
- the coating is applied by standard coating techniques to a solid-phase surface to create the immunosubstrate of the present invention.
- a droplet of a particular immunoreagent such as an antibody or antigen
- a particular immunoreagent such as an antibody or antigen
- the immunosubstrate, with the immunoreagent in place, is now ready for instantaneous future use for testing in the immunoassays associated with the particular immuno reagent.
- the immunoreagent may be added to the surface coating prior to the application thereof on a solid-phase surface to produce similar results.
- humectants and flow enhancers may be added to the surface coating or as an additional overcoating to aid in the penetration of the immunosubstrate coating by a test serum.
- a primary advantage of the surface coating of the present invention is that it is has greateradsorptive properties than non-coated solid-phase surfaces.
- an immunoreagent may be placed thereon to impregnate the coating, whereupon the immunosubstrate contains the immunoreagent in a form ready for instantaneous future use.
- Fig. 1 depicts a magnified cross sectional view of the surface coating of the present invention as applied to a porous solid-phase surface
- Fig. 2 depicts a magnified cross sectional view of the surface coating of the present invention as applied to a non-porous solid-phase surface
- Fig. 3 depicts the addition of an immunoreagent to the immunosubstrate shown in Fig. 1;
- Fig. 4 depicts the immunoreactive immunosubstrate shown in Fig. 3 after an over-coating has been applied thereto;
- Fig. 5 depicts the utilization of the immunoreactive immunosubstrate of the instant invention in a fluorescent testing situation.
- the surface coating for a solid-phase surface of the present invention comprises a water based emulsion of dispersed polymer beads of microdiameter size.
- the utilization of such polymer beads in a water based emulsion produces a superior substance for protein binding, and where the "bound proteins are immunoreagents such as antibodies or antigens an excellent immunosubstrate is created .
- a bead diameter of 0.1 to 1.0 microns has been found to produce excellent results. Larger bead diameters present little problem until their size affects the consistency of the coating or the ability of the beads to penetrate into a porous solid-phase surface as is hereinafter described.
- emulsifiers are known to those skilled in the art to create an emulsion of the water-bead mixture, a suitable emulsifier being an ammonium soap of a fatty acid.
- a suitable emulsifier being an ammonium soap of a fatty acid.
- Suitable materials for providing light scattering centers have been found to be starch, titanium dioxide, silicon dioxide and finely powdered clays such as kaolin. However , the quantity of such materials must be controlled as an increase in nonspecific binding of immunoreagents can be noted with increasing amounts of light scattering centers. This effect is particularly pronounced where titanium dioxide or clay is utilized.
- the basic surface coating according to the present invention is therefore primarily a water based latex bead emulsion which may contain additional substances that contribute light scattering centers.
- composition by weight may vary from approximately 30% latex polymer beads 69% water
- emulsifying agent 1% emulsifying agent to a formulation including light scattering centers which has a composition by weight of approximately: 15% light scattering centers 15% latex polymer beads
- a formulation of a preferred embodiment of the surface coating of the present invention comprises the following approximate composition by weight: 4% butadiene-styrene copolymer 7% polyvinyl acetate polymer 4.5% titanium dioxide 6.8% silicon dioxide
- the coating may be applied to a solid-phase surface by any of the standard application techniques; thus brushing, spraying, sponging, blade coating, rolling, dipping or droplet depositing, as well as other standard techniques, may be utilized for its application.
- the coating may be applied to either porous or non-porous solid-phase surfaces.
- Fig. 1 is a cross sectional. view of a surface coating 12 according to the instant invention as applied to a porous solid-phase surface 14
- Fig. 2 is a cros.s sectional view of a surface coating 12 accordinging to the instant invention as applied to a non-porous solid-phase surface 15. The difference between the two coated surfaces of Fig. 1 and Fig.
- a porous surface 14 may consist of a paper-like material composed of matted cellulosic fibers 20.
- the fiber 20 diameters must be considerably larger than the wavelengths of visible light, such that any light entering the disordered matrix of fibers will be scattered about by reflections from the fiber-liquid interface. Fiber diameters exceeding 0.4 to 0.7 microns have been found to be quite suitable.
- the light scattering centers component 17 of the coating is particularly important where the coating is applied to a porous surface, as good immunoassay results utilizing, optical methods require light penetration to significant depths within the porous material. The light scattering centers aid in obtaining such light penetration.
- a non-porous solid-phase surface 15 for the coating may be metal, glass or any of the various plastic materials that have been utilized in the prior art.
- the coating when utilized on a non- porous surface , provides a thickness to the immunoad sorbant layer in which the immunochemical reactions occur. This thickness creates a volume in which reactions occur and, as it results in an increased amount of adsorbed immunor e ac ⁇ en t per unit of surface area over a non-coated solid-phase surface, it thereby generally produces a more sensitive immunoassay than a non-coated solid-phase surface.
- a coating thickness of approximately 0.1 millimeters has been found to produce good results.
- an immunosubstrate 19 After a solid-phase surface has been coated, it is termed an immunosubstrate 19. As shown in Fig. 3, it may then be prepared for a particular immunochemical reaction by selecting an immunoreagent, such as a diluted antigen, antibody or enzyme solution, and wetting surface of the immunosubstrate with a few droplets 22 thereof. Humectants and wetting agents such as hydroxypropylmethyl cellulose may be added to the immunoreagent solution to speed the wetting process. Where a porous surface has been utilized, the immunoreagent solution penetrates into the coating and wets the body of the porous material, causing fiber swelling 24. The polymer beads 16 and light scattering centers 17 are carred into the fibrous mesh of the porous material where they are entrapped 26.
- an immunoreagent such as a diluted antigen, antibody or enzyme solution
- Humectants and wetting agents such as hydroxypropylmethyl cellulose
- the immunoreagent is also carried into the mesh and adsorbed onto the entrapped polymer beads 16.
- the immunoreagent impregnated porous immunosubstrate is then allowed to dry. As the moisture evaporates during the drying process, the fibers return to their original unswollen size and positions, but now firmly enmesh the dried immunoreagent, thus providing an exceedingly stable immunoreact ive immunosubstrate.
- An alternative embodiment, that has been utilized for the production of an immunoreactive immunosubstrate comprises the addition of an immunoreagent directly to the surface coating described hereinabove prior to the coating of a solid-phase surface. The addition of the immunoreagent to the surface coatin creates an immunoreactive surface coating.
- immunoreagent Approximately 0.01% by weight of immunoreagent is added to the surface coating formulation in this embodiment. However, the amount of immunoreagent will vary depending upon the exact immunoreagent being utilized and the desired sensitivity of the immunoreactive immunosubstrate being formed.
- the immunoreactive surface coating may then be applied to a solids-phase surface in any of the above-mentioned standard application methods.
- the resulting immunoreactive immunosubstrate can be made everywhere reactive on its surface by a uniform coating of the immunoreactive surface coating on the solid-phase or it can be made reactive in localized areas by placing droplets of immunoreactive surface coating at discrete locations on the solid-phase.
- an immunoreactive immunosubstrate 27 may be made even more sensitive by then overcoating the surface thereof with a coating 28 of basically the same ingredients as the instant coating, but containing a higher percentage of the polymer beads 16.
- a typical overcoating liquid comprises substan tially the following formulation by weight: Stock emulsion:
- the immunoreactive immunosubstrate 27 may be utilized according to the following description.
- the immunosubstrate having been previously impregnated with a specific antigen, is exposed to body fluid containing unknown amounts of an antibody directed at the specific antigen.
- the body fluid wets the coating and works its way through the thickness thereof . If the solid-phase is porous the body fluid penetrates into the mesh in the same manner as did the immunoreagent droplets 22.
- Any antibody present in the body fluid binds immuno chemically to its specific antigen on the polymer beads.
- the immunosubstrate After washing, to remove any fluid and unbound antibody, the immunosubstrate is exposed to an antihuman immunoglobulin made in another species (for example, goat antihuman immunoglobulin IgG or rabbit antihuman immunoglobulin IgM) . If any of the human antibody had been present in the fluid it would be bound to the specific antigen within the coating, and the goat antibody would bind immunochemically to it as it worked its way through the coating thickness.
- an antihuman immunoglobulin made in another species (for example, goat antihuman immunoglobulin IgG or rabbit antihuman immunoglobulin IgM) . If any of the human antibody had been present in the fluid it would be bound to the specific antigen within the coating, and the goat antibody would bind immunochemically to it as it worked its way through the coating thickness.
- the goat antihuman antibody is labeled with a detectable tracer such as a radioactive tag, a fluorescent dye, or other standard tag.
- a detectable tracer such as a radio label, such as iodine (125 I )
- a scintillation counter can be employed to quantitate the amount of label and, by calibration, the amount of human antibody bound in the immunolog ical reaction.
- a fluorochrome label such as fluorescein isothiocyanate (FITC)
- FITC fluorescein isothiocyanate
- any fluorometer capable of reading solid surfaces will be able to read the strength of fluorescence signal from the immunosubstrate, and thereby quantitate the amount of human antibody bound in the immunological reaction. In one type of fluorescence testing, as depicted in Fig.
- a blue photon 30 is isolated through the use of an excitation filter 31 and directed at the immunoreactive immunosubstrate 27. It will eventually either be absorbed by a molecule other than FITC, in which case it will raise the temperature of the immunosubstrate minutely by vibrational decay, or it will be absorbed by the FITC molecule, in which case, with a very high probability (greater than 90%) , it will make a singlet-singlet transition and release one green photon. In its emersion from the FITC, however, the green photon will either be lost to absorption by some other molecules or it will come out 32 of the immunosubstrate for detection by a photoelectric transducer 34 through the use of an emission filter 33 which passes only green photons.
- the advantage that occurs in an immunosubstrate containing many scattering centers is that the bouncing about of the blue photon from the center increases its chance of eventual absorption by an FITC molecule which may not have been in its direct flight path. Also, the emerging green photon has a greater probability of being detected in a single direction if it makes many flight path changes, as are created by the scattering centers. Thus, the increase in number of scattering centers will tend to increase the fluorescence of the sample.
- the immunosubstrate of the present invention shows considerably better binding properties. At 200 ⁇ gm of protein per unit of surface area, the mixed cellulose esters will lose almost 80% in the first wash, while the immunosubstrate will lose less than 50%.
- EXAMPLE II - Mixed Antigens in the Substrate Detection of a Mixture of Serum Antibodies
- rheumatolog ists and clinicians have relied on the ANA test (anti-nuclear antibodies) as a reliable screen for connective tissue diseases such as Systemic Lupus Erythamatosus (SLE) and
- ANA tests have thus been performed with cellular components consisting of salmon sperm nuclei separated from cells, and with a solubilized mixture of the most significant antigens considered stimuli to the anti-nuclear antibodies, such as double stranded deoxyr ibonucl e ic acid (D-DNA) , nucleohistones ( DNA-proteins ) and ribonucleic acid (RNA) .
- D-DNA double stranded deoxyr ibonucl e ic acid
- RNA ribonucleic acid
- ASNA antibodies to soluble nuclear antigens
- Results reported with various antigen-substrate combinations are shown in Table II, including both porous and non-porous solid-phase immunosubstrates.
- a butadiene-styrene copolymer was utilized in the surface coating.
- Case 2 Suspended human epithelial cells fixed to solid plastic substrates and read in objective fluorometer. Fluorescence greater than 40 is positive for ANA.
- Case 3 Disclosed coating, blade coated on a porous cellulose base and wetted with the mix of soluble antigens (ASNA) or whole nuclei (salmon or herring sperm nuclei) . Fluorescence greater than 60 is positive for ANA.
- Case 4 Liquid coating material, dropped onto solid plastic base, dried, then wetted with soluble antigens (ASNA) . Fluorescence greater than 60 is positive for ANA.
- Case 5 Soluble antigens (ASNA) blended into liquid coating material, then deposited on solid plastic base.
- Fluorescence greater than 60 is positive for ANA. Comparison of the results for cases 3, 4 and 5 shows that the coating, as opposed to the surface to which it is applied, is a determining factor in the results obtained, and that the immunoreagent can be incorporated into the liquid surface coating prior to coating the solid-phase surface.
- Example II Viral Antigen in Body Fluid
- Example II demonstrates that the instant coating is usable on non-porous as well as porous surfaces
- a modification of the typical coating formulatpn is made.
- the amount of light scattering centers is reduced , and the polymer beads (emulsion of polyvinyl acetate beads) represents a much greater percentage of the coating.
- This coating is much like the overcoating stock emulsion formulation described hereinabove.
- this modified mixture When this modified mixture is deposited in 25 ⁇ 1 droplets on a smooth, hard solid-phase surface, a thick coating is formed. While milky in its liquid state, it dries to clear , hard and glossy textured spots .
- 25 ⁇ 1 of commercially available rubella antigen is deposited on the film spots. The antigen, in aqueous suspension, penetrates the thick film spots and binds with the polymer beads therein. The immunoreactive immunosubstrate is allowed to dry for storage until it is to be used in an assay. In an assay, upon incubation with diluted serum, plasma, urine , saliva, etc.
- the immuno reaction occurs in the wetted spot and a milkiness is manifested due to the difference in refractive index between the polymer beads and the aqueous medium. Since the test spot is read wet in a fluorometer, this milkiness provides much of the optical light scattering properties for which other materials such as starch, clay or titanium dioxide were previously employed.
- the immuno absorptive surface coating of the present invention is a unique substance comprising a water based emulsion of polymer beads of microdiameter size to which light scattering centers may be added; the concentrations of these constituents being variable according to the above description.
- the coating has the ability to adsorb immunoreagents within its thickness whereby more sensitive testing is accomplished.
- the coating may be applied both to porous and non-porous solid-phase surfaces to create an immunosubstrate which shows reduced loss of immunoreagent upon washing. Where an immunoreagent is added to the surface coating and allowed to dry on a solid-phase surface, an immunoreactive immunosubstrate is created having greater sensitivity and reliability than existing solid-phase surfaces.
Abstract
The field of the present invention is immunoassay. Disclosed is a solid-phase immunosubstrate (14), which has a surface coating (12) composed of a water based emulsion of microdiameter sized latex polymer beads (16) and materials which act as light scattering centers (17). The surface coating (12) has an immunoreagent added to it, in order to form an immunoreactive immunosubstrate (27). Also disclosed is a method for manufacturing a composite including the immunosubstrate and coating. The surface coating provides an immunoreagent adsorptive volume; thus permitting adsorption of larger quantities of immunoreagent than possible for prior art solid-phase immunosurfaces, and increasing assay sensitivity. Further, the coating will retain adsorbed immunoreagent against vigorous washing.
Description
Specification
IMMUNOSUBSTRATE AND IMMUNOADSORPTTVE SURFACE COATING FOR SOLID-PHASE IMMUNOSUBSTRATE
BACKGROUND OF THE INVENTION Field of the Invention
The present invention relates generally to solid-phase iiranuno substrates, for use in immunological assaying and more particularly to a surface coating or film for application to a solid-phase surface and to the immunosubstrate formed by the utilization of the surface coating.
Description of the Prior Art
Many solid-phase surfaces are presently employed in immunolog ical testing to which a protein, such as an antibody (specific immunoglobul in ) or an antigen
(any one of many protein or protein bound substances), may be adsorbed to form an immunosubstrate. The solid-phase may be a metallic surface, such as is employed in polarization change studies, or a glass or smooth plastic surface in which the protein is fixed onto the surface by air drying, heat denaturation or the use of organic fixing agents such as acetone, ethanol, methanol or formaldehyde. In some cases use is made of protein adherence to the polymer chains of certain plastics without a fixing process, such as in the adsorption of viral, bacterial , hormonal or other antigens to polypropylene and/or polystyrene test tube walls, beads or microtiter plates. Cellulose and cellulose derivatives, such as mixtures of cellulose acetates
and cellulose nitrates, have also been utilized as adsorptive surfaces for protein binding.
These prior art solid-phase surfaces are generally utilized without any surface coatings to alter the adsorptive character of the surface. A common problem with such surfaces is that care must be taken when washing the surface during test procedures to prevent the immunoreagents or analytes that have adhered to the surface from being removed therefrom. Additionally, the use of an uncoated surface limits the user to the surface area of that surface for immunoreagent adsorption, whereas an immuno adsorptive coating on the surface has a thickness which creates an immunoreagent adsoptive volume, thus permitting the adsorption of a greater quantity of immunoreagent and increasing the sensitivity of the assay.
The surface coating or film of the present invention is applied to solid-phase surfaces to increase adsorption and retention of immunoreagents. Its main constituent is a water based emulsion of microdiameter size polymer beads to which may be added a material which imparts light scattering centers into the coating. No prior art is known to the inventors that utilizes such polymer beads within a surface coating for solid-phase surfaces, nor that combines them with a material providing optical properties that improves the fluorescent testing capability of the immunosubstrate formed through the use of the surface coating.
SUMMARY OF THE PRESENT INVENTION It is therefore a primary objective of the present invention to provide a surface coating for a
solid-phase surface which aids in the adsorbtion and retention of immunoreagents.
It is another object of the present invention to provide a surface coating which may be applied to both porous and non-porous solid-phase surfaces. It is a further object of the present invention to provide a solid-phase immunosubstrate which is specifically useful in optical immunoassay techniques such as fluorescence studies or absorptometry or ref lectometry with enzyme label utilization.
The immunoadsorptive surface coating of the present invention includes a water based emulsion of dispersed polymer beads of microdiameter size. Where the coating is to be used in an optical testing situation, such as fluorescence testing, additional materials may be added to the coating to provide light scattering centers within the coating. In the surface coating of the preferred embodiment, the polymer may be an acrylic, polyvinyl acetate or butadiene-styrene copolymer or a combination thereof, and a source of light scattering centers may be starch, titanium dioxide, silicon dioxide or finely powdered clay or a combination thereof . The coating is applied by standard coating techniques to a solid-phase surface to create the immunosubstrate of the present invention.
For particular applications of the immunosubstrate of the present invention, a droplet of a particular immunoreagent , such as an antibody or antigen, may be placed on the immunosubstrate to penetrate thereinto and bind therewith. The immunosubstrate, with the immunoreagent in place, is now ready for instantaneous future use for testing in the immunoassays associated with the particular immuno
reagent. The immunoreagent may be added to the surface coating prior to the application thereof on a solid-phase surface to produce similar results.
As a further modification of the immunoreagent impregnated immunosubstrate of the present invention, humectants and flow enhancers may be added to the surface coating or as an additional overcoating to aid in the penetration of the immunosubstrate coating by a test serum. A primary advantage of the surface coating of the present invention is that it is has greateradsorptive properties than non-coated solid-phase surfaces.
It is another advantage of the surface coating of the present invention that it will retain the adsorbed immunoreagent against vigorous washing.
It is a further advantage of the surface coating of the present invention that it contains light scattering centers which provide improved optical properties to the immunosubstrate.
It is an advantage of the coated immunosubstrate of the present invention that an immunoreagent may be placed thereon to impregnate the coating, whereupon the immunosubstrate contains the immunoreagent in a form ready for instantaneous future use.
These and other objects and advantages of the present invention will no doubt become apparent to those of ordinary skill in the art after having read the following detailed description of the preferred embodiments which are illustrated in the several figures of the drawing.
IN THE DRAWING
Fig. 1 depicts a magnified cross sectional view of the surface coating of the present invention as applied to a porous solid-phase surface;
Fig. 2 depicts a magnified cross sectional view of the surface coating of the present invention as applied to a non-porous solid-phase surface;
Fig. 3 depicts the addition of an immunoreagent to the immunosubstrate shown in Fig. 1;
Fig. 4 depicts the immunoreactive immunosubstrate shown in Fig. 3 after an over-coating has been applied thereto; and
Fig. 5 depicts the utilization of the immunoreactive immunosubstrate of the instant invention in a fluorescent testing situation.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT The surface coating for a solid-phase surface of the present invention comprises a water based emulsion of dispersed polymer beads of microdiameter size. The utilization of such polymer beads in a water based emulsion produces a superior substance for protein binding, and where the "bound proteins are immunoreagents such as antibodies or antigens an excellent immunosubstrate is created . In the preferred embodiment, a bead diameter of 0.1 to 1.0 microns has been found to produce excellent results. Larger bead diameters present little problem until their size affects the consistency of the coating or the ability of the beads to penetrate into a porous solid-phase surface as is hereinafter described. It is to be noted, however, that a larger bead size will also reduce the available bead surface area for protein binding. Almost any material having good
protein binding properties and having the capability of being formulated into microdiameter size particles within a water based emulsion could be utilized in the instant surface coating invention. Materials producing superior results have proved to be in the general class of latex type polymers. Particular latex polymers such as acrylics, polyvinyl acetates and butad iene-styrene copolymers have provided excellent results in immunoreactions, and these polymers or combinations of them are utilized in the preferred embodiment. Many emulsifiers are known to those skilled in the art to create an emulsion of the water-bead mixture, a suitable emulsifier being an ammonium soap of a fatty acid. Where the surface coating is to be used in an optical testing situation, such as fluorescent testing, the addition of a substance which specifically provides light scattering centers within the coating has proved to increase the fluorescence of the test sample created through use of the surface coating. Such scattering centers are important because it is the nature of the instant coating to permit immunoreagents to permeate therethrough, and the scattering centers within the coating aid in the optical detection of such permeating immunoreagents and their immunoreactions.
Suitable materials for providing light scattering centers have been found to be starch, titanium dioxide, silicon dioxide and finely powdered clays such as kaolin. However , the quantity of such materials must be controlled as an increase in nonspecific binding of immunoreagents can be noted with increasing amounts of light scattering centers. This effect is particularly pronounced where titanium
dioxide or clay is utilized.
The basic surface coating according to the present invention is therefore primarily a water based latex bead emulsion which may contain additional substances that contribute light scattering centers.
Its basic formulation varies according to whether light scattering centers are to be added; thus its composition by weight may vary from approximately 30% latex polymer beads 69% water
1% emulsifying agent to a formulation including light scattering centers which has a composition by weight of approximately: 15% light scattering centers 15% latex polymer beads
1% emulsifying agent 69% water
Further refinements of these basic formulations involve the addition of preservatives, surfactants, pH buffers, fungicides and defoamers to provide various properties to the surface coating that are helpful in the manufacture, storage and usage of the coating and immunosubstrate described hereinafter. Thus a formulation of a preferred embodiment of the surface coating of the present invention comprises the following approximate composition by weight: 4% butadiene-styrene copolymer 7% polyvinyl acetate polymer 4.5% titanium dioxide 6.8% silicon dioxide
0.5% preservation 0.1% pH buffer 0.5% fungicide 0.5% defoamer
4.0% surfactants 1.0% emulsifier 71.1% water
The coating may be applied to a solid-phase surface by any of the standard application techniques; thus brushing, spraying, sponging, blade coating, rolling, dipping or droplet depositing, as well as other standard techniques, may be utilized for its application. The coating may be applied to either porous or non-porous solid-phase surfaces. Fig. 1 is a cross sectional. view of a surface coating 12 according to the instant invention as applied to a porous solid-phase surface 14 whereas Fig. 2 is a cros.s sectional view of a surface coating 12 accordinging to the instant invention as applied to a non-porous solid-phase surface 15. The difference between the two coated surfaces of Fig. 1 and Fig. 2 is the penetration 13 of the coating 12 into the surface 13 of the porous solid-phase 14 which is not found where a non-porous solid-phase 15 is utilized. It is noted that the polymer beads 16 are shown as circular elements and light scattering particulates 17 are shown as triangular elements, both of which are shown disproportionately large to aid in understanding the invention. A porous surface 14 may consist of a paper-like material composed of matted cellulosic fibers 20. For use in optical analysis, such as by fluorescence, the fiber 20 diameters must be considerably larger than the wavelengths of visible light, such that any light entering the disordered matrix of fibers will be scattered about by reflections from the fiber-liquid interface.
Fiber diameters exceeding 0.4 to 0.7 microns have been found to be quite suitable. Larger fiber diameters present little problem until their size affects the ability of the porous mesh to retain the coating in place. The light scattering centers component 17 of the coating is particularly important where the coating is applied to a porous surface, as good immunoassay results utilizing, optical methods require light penetration to significant depths within the porous material. The light scattering centers aid in obtaining such light penetration.
A non-porous solid-phase surface 15 for the coating may be metal, glass or any of the various plastic materials that have been utilized in the prior art. The coating , when utilized on a non- porous surface , provides a thickness to the immunoad sorbant layer in which the immunochemical reactions occur. This thickness creates a volume in which reactions occur and, as it results in an increased amount of adsorbed immunor e acμen t per unit of surface area over a non-coated solid-phase surface, it thereby generally produces a more sensitive immunoassay than a non-coated solid-phase surface. A coating thickness of approximately 0.1 millimeters has been found to produce good results.
After a solid-phase surface has been coated, it is termed an immunosubstrate 19. As shown in Fig. 3, it may then be prepared for a particular immunochemical reaction by selecting an immunoreagent, such as a diluted antigen, antibody or enzyme solution, and wetting surface of the immunosubstrate with a few droplets 22 thereof. Humectants and wetting agents such as hydroxypropylmethyl cellulose may be added to the immunoreagent solution to speed the wetting process.
Where a porous surface has been utilized, the immunoreagent solution penetrates into the coating and wets the body of the porous material, causing fiber swelling 24. The polymer beads 16 and light scattering centers 17 are carred into the fibrous mesh of the porous material where they are entrapped 26. The immunoreagent is also carried into the mesh and adsorbed onto the entrapped polymer beads 16. The immunoreagent impregnated porous immunosubstrate is then allowed to dry. As the moisture evaporates during the drying process, the fibers return to their original unswollen size and positions, but now firmly enmesh the dried immunoreagent, thus providing an exceedingly stable immunoreact ive immunosubstrate. An alternative embodiment, that has been utilized for the production of an immunoreactive immunosubstrate , comprises the addition of an immunoreagent directly to the surface coating described hereinabove prior to the coating of a solid-phase surface. The addition of the immunoreagent to the surface coatin creates an immunoreactive surface coating. Approximately 0.01% by weight of immunoreagent is added to the surface coating formulation in this embodiment. However, the amount of immunoreagent will vary depending upon the exact immunoreagent being utilized and the desired sensitivity of the immunoreactive immunosubstrate being formed. The immunoreactive surface coating may then be applied to a solids-phase surface in any of the above-mentioned standard application methods. The resulting immunoreactive immunosubstrate can be made everywhere reactive on its surface by a uniform coating of the immunoreactive surface coating on the solid-phase or it can be made reactive in localized
areas by placing droplets of immunoreactive surface coating at discrete locations on the solid-phase.
As shown in Fig. 4, an immunoreactive immunosubstrate 27 may be made even more sensitive by then overcoating the surface thereof with a coating 28 of basically the same ingredients as the instant coating, but containing a higher percentage of the polymer beads 16.
A typical overcoating liquid comprises substan tially the following formulation by weight: Stock emulsion:
10-20% light scattering centers 10-25% latex polymer beads 1% emulsifier plus water vehicle in amount to total
100% by weight of the stock emulsion. To 100 ml of the stock emulsion is added: .5 gm of carboxymethyl cellulose 1 ml of polyvinyl alcohol 1 ml of hydroxypropylmethyl cellulose as humectants and flow enhancers.
The immunoreactive immunosubstrate 27 may be utilized according to the following description.
The immunosubstrate , having been previously impregnated with a specific antigen, is exposed to body fluid containing unknown amounts of an antibody directed at the specific antigen. The body fluid wets the coating and works its way through the thickness thereof . If the solid-phase is porous the body fluid penetrates into the mesh in the same manner as did the immunoreagent droplets 22.
Any antibody present in the body fluid binds immuno
chemically to its specific antigen on the polymer beads.
After washing, to remove any fluid and unbound antibody, the immunosubstrate is exposed to an antihuman immunoglobulin made in another species (for example, goat antihuman immunoglobulin IgG or rabbit antihuman immunoglobulin IgM) . If any of the human antibody had been present in the fluid it would be bound to the specific antigen within the coating, and the goat antibody would bind immunochemically to it as it worked its way through the coating thickness.
The goat antihuman antibody is labeled with a detectable tracer such as a radioactive tag, a fluorescent dye, or other standard tag. In the case of a radio label, such as iodine (125I) , a scintillation counter can be employed to quantitate the amount of label and, by calibration, the amount of human antibody bound in the immunolog ical reaction. Where a fluorochrome label such as fluorescein isothiocyanate (FITC) is utilized, any fluorometer capable of reading solid surfaces will be able to read the strength of fluorescence signal from the immunosubstrate, and thereby quantitate the amount of human antibody bound in the immunological reaction. In one type of fluorescence testing, as depicted in Fig. 5, a blue photon 30 is isolated through the use of an excitation filter 31 and directed at the immunoreactive immunosubstrate 27. It will eventually either be absorbed by a molecule other than FITC, in which case it will raise the temperature of the immunosubstrate minutely by vibrational decay, or it will be absorbed by the FITC molecule, in which case, with a very high probability (greater than 90%) , it will make a singlet-singlet transition and release
one green photon. In its emersion from the FITC, however, the green photon will either be lost to absorption by some other molecules or it will come out 32 of the immunosubstrate for detection by a photoelectric transducer 34 through the use of an emission filter 33 which passes only green photons. The advantage that occurs in an immunosubstrate containing many scattering centers , .such as is described hereinabove, is that the bouncing about of the blue photon from the center increases its chance of eventual absorption by an FITC molecule which may not have been in its direct flight path. Also, the emerging green photon has a greater probability of being detected in a single direction if it makes many flight path changes, as are created by the scattering centers. Thus, the increase in number of scattering centers will tend to increase the fluorescence of the sample.
The instant surface coating and the imsiuno substrates formed therefrom have been studied employing both radioactive and fluorescence labels and utilizing both antibodies and antigens as immunoreagents. The following examples will highlight their properties. EXAMPLE I - Binding Capacity of the Immunosubstrate
Studies were carried out with radiolabeled (125I) antibody ( goat anti-human IgG) deposited in varying amounts on the surface of both a coated, porous surfaced immunosubstrate, as described herein-above, and, as a control, on commercially available immunosubstrate films of mixed esters of cellulose which are used frequently for protein binding applications. A butadiene-styrene copolymer was utilized in the surface coating.
Both were subjected to counts in a gamma counter prior to and following four vigorous washing steps in buffers for 30 minute periods. From Table I it can be seen that at low protein loading (50 μgm) both surfaces bind comparably, losing about 30% in a first wash and about half by the end of the fourth wash .
As heavier protein loadings are employed, the immunosubstrate of the present invention shows considerably better binding properties. At 200 μgm of protein per unit of surface area, the mixed cellulose esters will lose almost 80% in the first wash, while the immunosubstrate will lose less than 50%.
TABL
EXAMPLE II - Mixed Antigens in the Substrate Detection of a Mixture of Serum Antibodies For many years, rheumatolog ists and clinicians have relied on the ANA test (anti-nuclear antibodies) as a reliable screen for connective tissue diseases such as Systemic Lupus Erythamatosus (SLE) and
Rheumatoid Arthritis (RA).
Since these diseases are characterized by the presence of several antibodies directed at different antigens within the nucleus of mammalian cells, all tests to date have employed whole cells as the substrate. These tests are generally performed with sliced tissue sections or cultivated cell lines in monolayers on glass microscope slides for subjective readout in a fluorescence microscope. One manufacturer has deposited whole suspended epithelial cells on a plastic substrate and read out the fluorescence objectively in a specially designed f luorometer. The coating described hereinabove is capable of binding both cellular components and mixtures of solubilized antigens . ANA tests have thus been performed with cellular components consisting of salmon sperm nuclei separated from cells, and with a solubilized mixture of the most significant antigens considered stimuli to the anti-nuclear antibodies, such as double stranded deoxyr ibonucl e ic acid (D-DNA) , nucleohistones ( DNA-proteins ) and ribonucleic acid (RNA) . This test is termed an ASNA ( antibodies to soluble nuclear antigens) test.
Results reported with various antigen-substrate combinations are shown in Table II, including both porous and non-porous solid-phase immunosubstrates.
A butadiene-styrene copolymer was utilized in the surface coating.
Case 1 - Standard microscope readout on rat liver slices. neg = no fluorescence, 3+ is bright fluorescence, P = peripheral staining, D = diffuse staining, S = speckled staining of the cell nucleus.
Case 2 - Suspended human epithelial cells fixed to solid plastic substrates and read in objective fluorometer. Fluorescence greater than 40 is positive for ANA. Case 3 - Disclosed coating, blade coated on a porous cellulose base and wetted with the mix of soluble antigens (ASNA) or whole nuclei (salmon or herring sperm nuclei) . Fluorescence greater than 60 is positive for ANA. Case 4 - Liquid coating material, dropped onto solid plastic base, dried, then wetted with
soluble antigens (ASNA) . Fluorescence greater than 60 is positive for ANA. Case 5 - Soluble antigens (ASNA) blended into liquid coating material, then deposited on solid plastic base. Fluorescence greater than 60 is positive for ANA. Comparison of the results for cases 3, 4 and 5 shows that the coating, as opposed to the surface to which it is applied, is a determining factor in the results obtained, and that the immunoreagent can be incorporated into the liquid surface coating prior to coating the solid-phase surface.
EXAMPLE III - Determining Antibodies to a Specific
Viral Antigen in Body Fluid Whereas Example II demonstrates that the instant coating is usable on non-porous as well as porous surfaces, in this Example a modification of the typical coating formulatpn is made. The amount of light scattering centers is reduced , and the polymer beads (emulsion of polyvinyl acetate beads) represents a much greater percentage of the coating. This coating is much like the overcoating stock emulsion formulation described hereinabove.
When this modified mixture is deposited in 25 μ1 droplets on a smooth, hard solid-phase surface, a thick coating is formed. While milky in its liquid state, it dries to clear , hard and glossy textured spots . To make this an immunoreactive immunosubstrate, 25 μ1 of commercially available rubella antigen is deposited on the film spots. The antigen, in aqueous suspension, penetrates the thick film spots and binds with the polymer beads therein. The immunoreactive immunosubstrate is allowed to dry
for storage until it is to be used in an assay. In an assay, upon incubation with diluted serum, plasma, urine , saliva, etc. , the immuno reaction occurs in the wetted spot and a milkiness is manifested due to the difference in refractive index between the polymer beads and the aqueous medium. Since the test spot is read wet in a fluorometer, this milkiness provides much of the optical light scattering properties for which other materials such as starch, clay or titanium dioxide were previously employed.
In a study employing this immunoreactive immunosubstrate, a panel of 29 serum samples with known rubella hemaggl utination (HAI) titer were tested employing immunof luorescence techniques. A simultaneous test was conducted with a mixed cellulose esters surface. The comparison of these two surfaces when related to HAI is seen in the data presented in Table III.
In comparing the data in Table III a significant reduction in the number of false positives and false negatives is shown. The immunoreactive immunosubstrate thus presents more reliable test results than the standard cellulose immunosubstrate.
It can therefore be seen that the immuno absorptive surface coating of the present invention is a unique substance comprising a water based emulsion of polymer beads of microdiameter size to which light scattering centers may be added; the concentrations of these constituents being variable according to the above description. The coating has the ability to adsorb immunoreagents within its thickness whereby more sensitive testing is accomplished.
The coating may be applied both to porous and non-porous solid-phase surfaces to create an immunosubstrate which shows reduced loss of immunoreagent upon washing. Where an immunoreagent is added to the surface coating and allowed to dry on a solid-phase surface, an immunoreactive immunosubstrate is created having greater sensitivity and reliability than existing solid-phase surfaces.
Whereas, the preferred embodiments of the present invention has been described above, it is contemplated that other alterations and modifications may become apparent to those skilled in the art after having read the above disclosure. It is therefore intended that the appended claims be interpreted as covering all such alterations and modifications as fall within the true spirit and scope of the invention.
What is claimed is:
Claims
1. An immunoadsorptive surface coating for a solid-phase surface for use in immunological assay testing comprising a water based emulsion of dispersed polymer beads including latex polymer beads of microdiameter size, water and an emulsifying agent to promote the emulsification of latex polymer beads within said water.
2. An immunoadsorptive coating as recited in claim 1 wherein said beads are formed with a minimum diameter of 0.1 microns and said coating has a composition by weight of approximately 30%, latex polymer beads, 69% water and 1% emulsifying agent.
3. An immunoadsorptive coating as recited in claim 2 wherein said polymer beads are composed of one or more of the substances from the group consisting of acrylic polymers, polyvinyl acetate polymers and butadiene-styrene copolymers.
4. An immunoadsorptive coating as recited in claim 3 wherein a source of light scattering centers is added to said coating whereby the fluorescent properties of said coating are improved.
5. An immunoadsorptive coating as recited in claim 4 wherein said source of light scattering centers is composed of one or more of the substances from the group consisting of starch, titanium dioxide, silicon dioxide and finely ground clay.
6. An immunoadsorptive coating as recited in claim 5 wherein the concentration by weight of the components of said coating is approximately 15% light scattering centers, 15% polymer beads, 69% water and 1% emulsifying agent.
7. An immunoadsorptive coating as recited in claim 5 wherein preservatives, surfactants , pH buffers, fungicides and defoamers are added to said coating whereby the concentration by weight of the components of said coating is approximately 11% latex polymer beads, 11.3% light scattering centers, .5% preservatives, .1% pH buffers, .5% fungicides, .5% defoamers, 4.0% surfactants , 1.0% emulsifying agents and 71.1% water.
8. A solid-phase immunosubstrate for use in immunological assay testing comprising: a solid-phase surface; an immunoadsorptive surface coating being applied upon said surface, said coating comprising a water based emulsion of dispersed latex polymer beads including latex polymer beads of microdiameter size, water and an emulsifying agent to promote the emulsification of said latex polymer beads within said water.
9. An immunosubstrate as recited in claim 8 wherein said beads are formed with a minimum diameter of 0.1 microns, said coating having a composition by weight of approximately 30% latex beads, 69% water and 1% emulsifying agent.
10. An immunosubstrate as recited in claim 9 wherein said polymer beads are composed of one or more of the substances from the group consisting of acrylic polymer, polyvinyl acetate polymer and butad iene-styrene copolymers.
11. An immunosubstrate as recited in claim 10 wherein a source of light scattering centers is added to said coating whereby the fluorescent properties of said coating are improved.
12. An immunosubstrate as recited in claim 11 wherein said source of light scattering centers is composed of one or more of the substances from the group consisting of starch, titanium dioxide and finely ground clay.
13. An immunosubstrate as recited in claim 12 wherein the concentration by weight of the compnents of said coating is approximately 15% light scattering centers, 15% polymer beads, 69% water and 1% emulsifying agent.
14. An immunoadsorptive coating as recited in claim 13 wherein preservatives, surfactants, pH buffers, fungicides and defoamers are added to said coating whereby the concentration by weight of the components of said coating is approximately 11% latex polymer beads, 11.3% light scattering centers,
.5% preservatives, .1% pH buffers, .5% fungicides, .5% defoamers, 4.0% surfactants, 1.0% emulsifying agents and 71.1% water.
15. An immunoreactive surface coating for a solid-phase immunosubstrate for use in immunological assay testing comprising a water based emulsion of dispersed latex polymer beads, including latex polymer beads of microdiameter size, water, an immunoreagent and an emulsifying agent to promote the emulsif ication of said latex polymer beads within said water, whereby an immunoreactive surface coating is formed for use in specific immunόreactions which require said immunoreagent.
1 . An immunoreactive surface coating as recited in claim 15 wherein said beads are formed with a minimum diameter of 0.1 microns and said coating has a composition by weight of approximately 30% latex polymer beads, 68.99% water, 1% emulsifying agent, and 0.01% immunoreagent.
17. An immunoreactive surface coating as recited in claim 16 wherein said polymer beads are composed of one or more of the substances from the group consisting of acrylic polymers, polyvinyl acetate polymers and butadiene-styrene copolymers.
18. An immunoreactive surface coating as recited in claim 17 wherein a source of light scattering centers is added to said coating whereby the fluorescent properties of said coating are improved.
19. An immunoreactive surface coating as recited in claim 18 wherein said source of light scattering centers is composed of one or more of the substances from the group consisting of starch,
titanium dioxide and finely ground clay.
20. An immunoreactive surface coating as recited in claim 19 wherein the concentration by weight of the components of said coating is approximately 15% light scattering centers, 15% polymer beads, 68.99% water, 1% emulsifying agent and 0.01% immunoreagent.
21. An immunoreactive surface coating as recited in claim 19 wherein preservatives, surfactants, pH buffers, fungicides and defoamers are added to said coating whereby the concentration by weight of the components of said coating is approximately 11% latex polymer beads, 11.3% light scattering centers, .5% preservatives, .1% pH buffers, .5% fungicides, .5% defoamers, 4.0% surfactants, 1.0% emulsifying agents, 71.09% water and 0.01% immunoreagent.
22. A solid-phase immunoreactive immunosubstrate for use in immunological assay determinations comprising: a solid-phase surface; a water based emulsion of dispersed latex polymer beads, including latex polymer beads of microdiameter size, water and an emulsifying agent to promote the emulsif ication of said latex polymer beads within said water; and an immunoreagent being applied to said coating and adsorbed into said coating whereby an immunoreactive immunosubstrate is formed for use in specific immunoreactions which require said immunoreagent.
23. An immunoreactive immunosubstrate as recited in claim 22 wherein said beads are formed with a minimum diameter of 0.1 microns, said coating having a composition by weight of approximately 30% latex polymer beads, 68.99% water, 1% emulsifying agent and 0.01% immunoreagent.
24. An immunoreactive immunosubstrate as recited in claim 23 wherein said polymer beads are composed of one of the substances from the group consisting of acrylic polymers, polyvinyl acetate polymers and buted iene-styrene copolymers.
25. An immunoreactive immunosubstrate as recited in claim 24 wherein a source of light scattering centers is added to said coating whereby the fluorescent properties of said surface coating are improved.
26. An immunoreactive immunosubstrate as recited in claim 25 wherein said source of light scattering centers is composed of one or more of the substances from the group consisting of starch, titanium dioxide and finely ground clay.
27. An immunoreactive imm-uno subs tr ate as recited in claim 26 wherein the concentration by weight of the components of said coating is approximately 15% light scattering centers, 15% polymer beads, 68.99% water, 1% emulsifying agent and 0.01% immunoreagent.
28. An immunoreactive immunosubstrate as recited in claim 26 wherein preservatives,
surf actants, pH buffers, fungicides and defoamers are added to said coating whereby the concentration by weight of the components of said coating is approximately 11% latex polymer beads, 11.3% light scattering centers , .5% preservatives , .1% pH buffers , .5% fungas.ides , .5% defoamers , 4.0% surfactants, 1.0% emulsifying agents, 71.09% water and 0.01% immunoreagent.
29. A solid-phase immunosubstrate as recited in claims 11 or 25 wherein said surface coating is further coated with an overcoating comprising substantially the following formulation by weight: a liquid emulsion of 100 milliliters including
10 through 20% light scattering centers, 10 through 25% latex polymer beads, 1% emulsifying agents, plus a water vehicle in an amount sufficient to equal 100%; and added thereto is .5 grams of carboxymethyl cellulose, 1 milliliter of polyvinyl alcohol and 1 milliliter of hydroxypropylmethyl cellulose.
30. A method for manufacturing an immunosubstrate comprising selecting a solid-phase surface; applying to said solid-phase surface a surface coating which comprises a water based emulsion of latex polymer beads which includes latex polymer beads of microdiameter size, water and an emulsifying agent to promote the emulsification of said beads within said water; and drying said surface coating.
31. A method for manufacturing an immunosubstrate as recited in claim 30 wherein said latex
beads are formed with a minimum diameter of 0.1 microns and said coating has a composition by weight of approximately 30% latex polymer beads, 69% water and 1% emulsifying agent.
32. A method for manufacturing an immunosubstrate as recited in claim 31 wherein said polymer beads are composed of one or more of the substances from the group consisting of acrylic polymers, polyvinyl acetate polymers and butediene-styrene copolymers.
33. A method for manufacturing an immunosubstrate as recited in claim 32 wherein a source of light scattering centers is added to said coating whereby the fluorescent properties of said coating are improved.
34. A method for manufacturing an immunosubstrate as recited in claim 33 wherein said source of light scattering centers is composed of one or more of the substances from the group consisting of starch, titanium dioxide and finely ground clay.
35. A method for manufacturing an immunosubstrate as recited in claim 34 wherein the concentration by weight of the components of said coating is approximately 15% light scattering centers, 15% polymer beads, 69% water and 1% emulsifying agents.
36. A method for manufacturing an immunosubstrate as recited in claim 34 wherein preservatives, surfactants, pH buffers, fungicides and defoamers are added to said coating whereby the concentration by
weight of the components of said coating is approximately 11% latex polymer beads, 11.3% light scattering centers, .5% preservatives, .1% pH buffers, .5% fungicides, .5% defoamers, 4.0% surfactants, 1.0% emulsifying agents and 71.1% water.
37. A method for manufacturing an immunoreactive immunosubstrate comprising selecting a solid-phase surface; applying to said solid-phase surface a surface coating which comprises a water based emulsion of latex polymer beads which includes latex polymer beads of microdiameter size, water and an emulsifying agent to promote the emulsif ication of said beads within said water; applying to said surface coating a solution containing an immunoreagent which will become adsorbed to said polymer beads; and drying said solution and surface coating.
38. A method for manufacturing an immunoreactive immunosubstrate comprising selecting a solid-phase surface; applying to said solid-phase surface an immunoreactive surface coating which comprises an immunoreactive water based emulsion of latex polymer beads which includes latex polymer beads of microdiameter size, water, an immunoreagent and an emulsifying agent to promote the emulsif ication of said beads within said water; and drying said surface coating.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU74514/81A AU7451481A (en) | 1980-07-21 | 1981-07-20 | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/170,632 US4340564A (en) | 1980-07-21 | 1980-07-21 | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate |
US170632800721 | 1980-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1982000363A1 true WO1982000363A1 (en) | 1982-02-04 |
Family
ID=22620684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1981/000973 WO1982000363A1 (en) | 1980-07-21 | 1981-07-20 | Immunosubstrate and immunoadsorptive surface coating for solid-phase immunosubstrate |
Country Status (3)
Country | Link |
---|---|
US (1) | US4340564A (en) |
EP (1) | EP0056055A1 (en) |
WO (1) | WO1982000363A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0111042A1 (en) * | 1982-12-01 | 1984-06-20 | Fuji Pharmaceutical Ind. Co., Ltd. | Diagnostic testing slide and diagnostic testing plate, and method of producing same |
FR2544081A1 (en) * | 1983-04-07 | 1984-10-12 | Daryl Lab Inc | SUBSTRATE FOR IMMUNOFLUORESCENCE ANALYSIS |
WO1986006491A1 (en) * | 1985-04-25 | 1986-11-06 | Dr. L. Willems Instituut | Immunoactive components immobilized in a porous material |
GB2183344B (en) * | 1985-10-08 | 1990-03-14 | Sharp Kk | Sensor |
WO1992010743A1 (en) * | 1990-12-11 | 1992-06-25 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method of determining a specific ligand in a liquid sample with the aid of an acoustic measuring device, and a component of the measuring device |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
US4447529A (en) * | 1981-07-06 | 1984-05-08 | Miles Laboratories, Inc. | Preparing homogeneous specific binding assay element to avoid premature reaction |
JPS5818167A (en) * | 1981-07-24 | 1983-02-02 | Fuji Photo Film Co Ltd | Analyzing film and analysis using said film |
US4582793A (en) * | 1982-10-29 | 1986-04-15 | Research Corporation | Anti-RNA polymerase I antibody test for the diagnosis of rheumatological diseases |
US4596723A (en) * | 1984-05-02 | 1986-06-24 | Daryl Laboratories, Inc. | Immunoassay substrate |
US5879881A (en) * | 1985-04-04 | 1999-03-09 | Hybritech, Incorporated | Solid phase system for use in ligand-receptor assays |
TW203120B (en) * | 1985-10-04 | 1993-04-01 | Abbott Lab | |
US5501949A (en) * | 1985-12-10 | 1996-03-26 | Murex Diagnostics Corporation | Particle bound binding component immunoassay |
US4916056A (en) * | 1986-02-18 | 1990-04-10 | Abbott Laboratories | Solid-phase analytical device and method for using same |
US5073344A (en) * | 1987-07-17 | 1991-12-17 | Porex Technologies Corp. | Diagnostic system employing a unitary substrate to immobilize microspheres |
FR2638234B1 (en) * | 1988-10-21 | 1992-11-27 | Rhone Poulenc Chimie | SUPPORT FOR BIOLOGICALLY ACTIVE OR ITSELF BIOLOGICALLY ACTIVE MOLECULES, ITS PREPARATION METHOD AND ITS APPLICATION IN BIOLOGY |
DE4439348A1 (en) * | 1994-11-04 | 1996-05-09 | Boehringer Mannheim Gmbh | White trigger preparations to improve signal detection in bio- and chemiluminescent reactions |
EP0852004B1 (en) * | 1995-10-11 | 2011-01-19 | Luminex Corporation | Multiplexed analysis of clinical specimens |
US6449562B1 (en) | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
US20030068827A1 (en) * | 2001-10-05 | 2003-04-10 | Ocean Optics, Inc. | Enhanced scattering membranes for improved sensitivity and signal-to-noise of optical chemical sensors, fiber optic oxygen sensor for real time respiration monitoring utilizing same, and method of using sensor |
US20050164261A1 (en) * | 2001-10-09 | 2005-07-28 | Chandler Don J. | Multiplexed analysis of clinical specimens apparatus and methods |
US8148171B2 (en) | 2001-10-09 | 2012-04-03 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
EP1739407B1 (en) * | 2004-05-06 | 2018-05-30 | Panasonic Intellectual Property Management Co., Ltd. | Sensor, measuring equipment and measuring method |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3770383A (en) * | 1971-04-05 | 1973-11-06 | Akzona Inc | Diagnostic test slide |
US3853987A (en) * | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3950600A (en) * | 1973-07-27 | 1976-04-13 | Ing. C. Olivetti & C., S.P.A. | Thermosensitive element, and its employ in the thermographic reproduction or record systems |
US3957741A (en) * | 1974-01-17 | 1976-05-18 | California Institute Of Technology | Crosslinked, porous, polyacrylate beads |
US3992517A (en) * | 1975-02-19 | 1976-11-16 | Pfizer Inc. | Detection of hepatitis B surface antigen by latex agglutination |
US4003988A (en) * | 1976-06-01 | 1977-01-18 | Warner-Lambert Company | Direct agglutination test for pregnancy |
US4042335A (en) * | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
US4094841A (en) * | 1974-06-17 | 1978-06-13 | The Dow Chemical Company | Highly monodisperse latexes of non-film forming polymers |
US4113687A (en) * | 1977-08-10 | 1978-09-12 | Sintef | Process for preparing latex |
US4137208A (en) * | 1976-05-06 | 1979-01-30 | Berger, Jenson & Nicholson Limited | Coating composition |
US4138383A (en) * | 1975-11-24 | 1979-02-06 | California Institute Of Technology | Preparation of small bio-compatible microspheres |
US4157323A (en) * | 1976-06-09 | 1979-06-05 | California Institute Of Technology | Metal containing polymeric functional microspheres |
US4186120A (en) * | 1976-11-22 | 1980-01-29 | Sintef (Selskapet For Industriell Og Teknisk Forskning Ved Nth) | Process for producing finely divided aqueous emulsions from materials of limited water solubility |
US4194877A (en) * | 1977-11-28 | 1980-03-25 | United States Of America | Dye-containing polymer composition |
US4226847A (en) * | 1977-06-21 | 1980-10-07 | Morinaga Milk Industry Co., Ltd. | Latex polymer sensitized with steroid-serum albumin conjugate, preparation and test therewith |
US4241143A (en) * | 1978-03-17 | 1980-12-23 | Mitsubishi Paper Mills, Ltd. | Process for producing highly glossy coated paper |
US4243416A (en) * | 1975-10-08 | 1981-01-06 | Rohm And Haas Company | Corrosion-inhibiting method using latex paints and article |
US4247434A (en) * | 1978-12-29 | 1981-01-27 | Lovelace Alan M Administrator | Process for preparation of large-particle-size monodisperse |
US4258001A (en) * | 1978-12-27 | 1981-03-24 | Eastman Kodak Company | Element, structure and method for the analysis or transport of liquids |
US4264766A (en) * | 1877-09-19 | 1981-04-28 | Hoffmann-La Roche Inc. | Immunological diagnostic reagents |
-
1980
- 1980-07-21 US US06/170,632 patent/US4340564A/en not_active Expired - Lifetime
-
1981
- 1981-07-20 WO PCT/US1981/000973 patent/WO1982000363A1/en unknown
- 1981-07-20 EP EP81902154A patent/EP0056055A1/en not_active Withdrawn
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4264766A (en) * | 1877-09-19 | 1981-04-28 | Hoffmann-La Roche Inc. | Immunological diagnostic reagents |
US3770383A (en) * | 1971-04-05 | 1973-11-06 | Akzona Inc | Diagnostic test slide |
US3853987A (en) * | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3950600A (en) * | 1973-07-27 | 1976-04-13 | Ing. C. Olivetti & C., S.P.A. | Thermosensitive element, and its employ in the thermographic reproduction or record systems |
US3957741A (en) * | 1974-01-17 | 1976-05-18 | California Institute Of Technology | Crosslinked, porous, polyacrylate beads |
US4094841A (en) * | 1974-06-17 | 1978-06-13 | The Dow Chemical Company | Highly monodisperse latexes of non-film forming polymers |
US3992517A (en) * | 1975-02-19 | 1976-11-16 | Pfizer Inc. | Detection of hepatitis B surface antigen by latex agglutination |
US4042335A (en) * | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
US4243416A (en) * | 1975-10-08 | 1981-01-06 | Rohm And Haas Company | Corrosion-inhibiting method using latex paints and article |
US4138383A (en) * | 1975-11-24 | 1979-02-06 | California Institute Of Technology | Preparation of small bio-compatible microspheres |
US4137208A (en) * | 1976-05-06 | 1979-01-30 | Berger, Jenson & Nicholson Limited | Coating composition |
US4003988A (en) * | 1976-06-01 | 1977-01-18 | Warner-Lambert Company | Direct agglutination test for pregnancy |
US4157323A (en) * | 1976-06-09 | 1979-06-05 | California Institute Of Technology | Metal containing polymeric functional microspheres |
US4186120A (en) * | 1976-11-22 | 1980-01-29 | Sintef (Selskapet For Industriell Og Teknisk Forskning Ved Nth) | Process for producing finely divided aqueous emulsions from materials of limited water solubility |
US4226847A (en) * | 1977-06-21 | 1980-10-07 | Morinaga Milk Industry Co., Ltd. | Latex polymer sensitized with steroid-serum albumin conjugate, preparation and test therewith |
US4113687A (en) * | 1977-08-10 | 1978-09-12 | Sintef | Process for preparing latex |
US4194877A (en) * | 1977-11-28 | 1980-03-25 | United States Of America | Dye-containing polymer composition |
US4241143A (en) * | 1978-03-17 | 1980-12-23 | Mitsubishi Paper Mills, Ltd. | Process for producing highly glossy coated paper |
US4258001A (en) * | 1978-12-27 | 1981-03-24 | Eastman Kodak Company | Element, structure and method for the analysis or transport of liquids |
US4247434A (en) * | 1978-12-29 | 1981-01-27 | Lovelace Alan M Administrator | Process for preparation of large-particle-size monodisperse |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0111042A1 (en) * | 1982-12-01 | 1984-06-20 | Fuji Pharmaceutical Ind. Co., Ltd. | Diagnostic testing slide and diagnostic testing plate, and method of producing same |
FR2544081A1 (en) * | 1983-04-07 | 1984-10-12 | Daryl Lab Inc | SUBSTRATE FOR IMMUNOFLUORESCENCE ANALYSIS |
WO1986006491A1 (en) * | 1985-04-25 | 1986-11-06 | Dr. L. Willems Instituut | Immunoactive components immobilized in a porous material |
GB2183344B (en) * | 1985-10-08 | 1990-03-14 | Sharp Kk | Sensor |
WO1992010743A1 (en) * | 1990-12-11 | 1992-06-25 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method of determining a specific ligand in a liquid sample with the aid of an acoustic measuring device, and a component of the measuring device |
Also Published As
Publication number | Publication date |
---|---|
EP0056055A1 (en) | 1982-07-21 |
US4340564A (en) | 1982-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4340564A (en) | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate | |
US4430436A (en) | Analytical element and method of use | |
CA2091255C (en) | Microassay on a card | |
EP0560411B1 (en) | Specific binding assays | |
US5160486A (en) | Test carrier utilizing reaction of two bioaffine binding partners | |
US4670381A (en) | Heterogeneous immunoassay utilizing horizontal separation in an analytical element | |
US5212060A (en) | Dry test strip comprising a dextran barrier for excluding erythrocytes | |
US4258001A (en) | Element, structure and method for the analysis or transport of liquids | |
AU723534B2 (en) | Optical quantification of analytes in membranes | |
US5714340A (en) | Immunoassay elements having a receptor zone | |
EP0564494B1 (en) | Test method and reagent kit therefor | |
US5166079A (en) | Analytical assay method | |
US20100317126A1 (en) | Agglutination assay method in porous medium layer | |
US5266460A (en) | Method of preparing immunological analytical element | |
JPS5915861A (en) | Material for immune analysis | |
EP0287731A2 (en) | Dry test strips having a red blood cell exclusion layer | |
JP4437211B2 (en) | Measuring method using immunochromatography and sample analysis tool used therefor | |
JPS6329246A (en) | Analytic element having development adjusting zone | |
JPH0219903B2 (en) | ||
JPH01227964A (en) | Production of immunological analysis element | |
WO1990005914A1 (en) | Biological diagnostic assay system | |
USH1664H (en) | Analytical element for immunoassay and method for its preparation | |
JP2003262637A (en) | Inspection piece and inspection method | |
JPH0424660B2 (en) | ||
JPH01237455A (en) | Dry immunity analyzing element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): AU BR DK JP |
|
AL | Designated countries for regional patents |
Designated state(s): AT CH DE FR GB NL SE |